PGENPRECIGEN, INC.vs its industry peers
A metric-by-metric comparison of PRECIGEN, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGENThis | $1.9B#3 | — | 42.5x#5 | 191.3x#4 | 146.7%#1 | -98.6%#4 | -1141.1%#3 | -575.1%#5 | -91.2%#2 | — | — | — |
| ZBIO | $1.9B#2 | — | 7.6x#2 | 188.2x#3 | 100.0%#2 | -140.6%#5 | -3830.6%#4 | -152.9%#4 | -296.6%#3 | — | — | — |
| SLS | $1.8B#4 | — | 12.9x#4 | — | -100.0%#5 | 13.0%#1 | — | -19.5%#2 | — | — | — | — |
| SUPN | $1.7B#5 | — | 1.6x#1 | 2.4x#1 | 8.6%#4 | -152.2%#6 | -8.7%#1 | -3.6%#1 | -4.8%#1 | — | — | — |
| RARE | $1.7B#6 | — | — | 2.5x#2 | 20.2%#3 | -1.1%#2 | -79.5%#2 | — | — | — | -49.7%#1 | — |
| TRAX | $1.9B#1 | — | 12.8x#3 | — | — | -1.5%#3 | — | -110.0%#3 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice